You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Details for New Drug Application (NDA): 207917


✉ Email this page to a colleague

« Back to Dashboard


NDA 207917 describes EPIDUO FORTE, which is a drug marketed by Galderma Labs and is included in one NDA. It is available from two suppliers. Additional details are available on the EPIDUO FORTE profile page.

The generic ingredient in EPIDUO FORTE is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.
Summary for 207917
Tradename:EPIDUO FORTE
Applicant:Galderma Labs
Ingredient:adapalene; benzoyl peroxide
Patents:0
Pharmacology for NDA: 207917
Suppliers and Packaging for NDA: 207917
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917 NDA Galderma Laboratories, L.P. 0299-5906 0299-5906-00 2 g in 1 TUBE (0299-5906-00)
EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917 NDA Galderma Laboratories, L.P. 0299-5906 0299-5906-02 1 TUBE in 1 BLISTER PACK (0299-5906-02) / 2 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.3%;2.5%
Approval Date:Jul 15, 2015TE:ABRLD:Yes

Expired US Patents for NDA 207917

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galderma Labs EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917-001 Jul 15, 2015 ⤷  Sign Up ⤷  Sign Up
Galderma Labs EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917-001 Jul 15, 2015 ⤷  Sign Up ⤷  Sign Up
Galderma Labs EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917-001 Jul 15, 2015 ⤷  Sign Up ⤷  Sign Up
Galderma Labs EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917-001 Jul 15, 2015 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.